Tapeworm DNA contains drug weak spots

Existing drugs could be effective in treating this damaging parasite, the first full tapeworm genomes reveal

For the first time, researchers have mapped the genomes of tapeworms to reveal potential drug targets on which existing drugs could act. The genomes provide a new resource that offers faster ways to develop urgently needed and effective treatments for these debilitating diseases.

Tapeworms cause two of the World Health Organization’s 17 neglected tropical diseases; echinococcosis and cysticercosis. The team sequenced the genomes of four species of tapeworm to explore the genetics and underlying biology of this unusual parasite. As an adult it can live relatively harmlessly in the gut, but its larvae can spread through the body with devastating effects. The larvae form cysts in the internal organs or tissues of humans and other animals. These cysts proliferate or grow in the body, much like cancer. In some species this can cause complications such as blindness and epilepsy, with others it may lead to death.

“Tapeworm infections are prevalent across the world and their devastating burden is comparable to that of multiple sclerosis or malignant melanoma. These genome sequences are helping us to immediately identify new targets for much-needed drug treatment. In addition, exploring the parasites’ full DNA sequences is driving our understanding of its complex biology, helping the research community to focus on the most effective drug candidates.”

Dr Matthew Berriman Senior author from the Wellcome Trust Sanger Institute

Normally, researchers identify new targets for drugs to combat diseases by comparing a pathogen’s genome sequence with the human host’s DNA to find differences between them. This time, however, the team deliberately looked for similarities between humans and the parasite because both are multicellular and the tapeworm is evolutionarily similar to humans. By finding similarities, the scientists found targets that exploit the activities of existing drugs. Identifying treatments already on pharmacy shelves and approved for other uses should save time and money.

Many of the processes of these diseases parallel those of cancer tumours, suggesting that tapeworms could be susceptible to cancer treatments, such as suppressing cell division and preventing DNA replication. When the team compiled a list of most likely targets for drug treatment, many of them were the same targets as pre-existing cancer chemotherapies.

Combining biological knowledge with the full genome also revealed other promising targets for existing drugs. Over time, tapeworms have lost the ability to synthesise the necessary fats and cholesterol that are crucial for larvae development. Instead, they scavenge and modify them from their hosts. The most active genes in the tapeworm are central to this important scavenging process because they produce the proteins that bind fats or are the precursors of fatty acid binding proteins. Disrupting these proteins with current drugs may prove an effective treatment.

“We have developed new method to grow tapeworm cells in the laboratory and we’re screening these cells against many of the potential drug treatments identified from the genomes. Given that so few successful treatment options are currently available, we hope that we will be able to identify and validate existing drug candidates, relieving the burden of this debilitating, overlooked disease.”

Professor Klaus Brehm Co-author from the University of Würzburg, Germany

As well as identifying targets that existing drugs could act on, the team discovered why other treatments have been unsuccessful. For example, targeting the acetylcholinesterases (enzymes present in the central nervous system) has been successful in treating malaria and fluke worms, but was ineffective against tapeworms. Analysing gene activity showed that the production of acetylcholinesterases is surprisingly low in tapeworm cysts, explaining why their disruption had no effect.

For one tapeworm species, the team managed to assemble essentially complete chromosomes. Surprisingly, this revealed a similar chromosomal organisation with the distantly related flukes. The quality and high level of genomic sequence in this study also enabled the team to examine the evolutionary genetic losses and gains of tapeworms, providing them with hundreds of potential drug targets and eliminating those targets that are unlikely to work against tapeworm infection.

“We need to take advantage of this genetic sequence data to find new and improved ways of coping with this problem that devastates much of the developed and developing world. Open access to these complete genomes will accelerate the pace in which we find alternative tools and treatments to combat tapeworm infections.”

Professor Peter Hotez Dean of the National School of Tropical Medicine at Baylor College of Medicine and Editor-in-Chief of PLoS Neglected Tropical Diseases

More information

Additional Quotes in support of the research

“These tapeworms have accompanied the human being throughout our recorded history; Taenia solium infections were already known in the times of Confucius in China as well as in the Aristotle’s Athens. Counting today with this group of genomes is somehow an historical achievement and is very exciting. New opportunities are open now for the treatment, prevention and control of these neglected diseases affecting a number of developing countries.”

Professor Juan P Laclette Co-author from the National University of Mexico

“These promising findings offer new hope for huge numbers of people around the world – especially the global poor. Findings like this remind us that when public and private financing is threatened or cut for research into diseases like tapeworm that is highly associated with poverty, real people and families are the victims. The public and private sectors must work together to reduce this needless suffering.”

David Walker President of the American Society of Tropical Medicine and Hygiene

Funding

The research was supported by The Wellcome Trust, the Universidad Nacional Autonóma de México, the Biotechnology and Biological Sciences Research Council, and a SynTax joint-UK Research Council grant.

Participating Centres

The following institutions supplied or sequenced the strains of tapeworms to allow genome sequencing: the Natural History Museum; the National University of México (Universidad Nacional Autónoma de México, UNAM); the University of Würzburg; the Chinese Academy of Agricultural Sciences; and the Wellcome Trust Sanger Institute.

A full list of participating centres can be found at the Nature website.